Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease
Condition(s):Diabetic NephropathiesLast Updated:September 14, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Diabetic NephropathiesLast Updated:September 14, 2023Completed
Condition(s):SchizophreniaLast Updated:April 24, 2019Withdrawn
Condition(s):Obesity; HypertensionLast Updated:September 29, 2022Recruiting
Condition(s):Obesity-Associated Insulin ResistanceLast Updated:November 13, 2023Suspended
Condition(s):Polycystic Ovary SyndromeLast Updated:November 2, 2018Completed
Condition(s):Obesity; HypertensionLast Updated:February 20, 2024Recruiting
Condition(s):Central Sympathetic Nervous System DiseasesLast Updated:September 29, 2022Completed
Condition(s):Hypertension; Abdominal Obesity; Metabolic SyndromeLast Updated:February 24, 2012Completed
Condition(s):Hypertension; Type 2 DiabetesLast Updated:January 30, 2009Completed
Condition(s):Hypertension; Left Ventricular HypertrophyLast Updated:August 16, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.